U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06806462) titled 'Biomolecular Markers of Bone Metastasis' on Nov. 28, 2024.
Brief Summary: The goal of this clinical trial is to characterize the biomolecular profile of bone metastases to define the predisposing profiles of bone metastasis, in patients with breast or lung or renal carcinomas or of the gastroenteric or prostate tract with bone metastasis.
The main question it aims to answer is:
Is it possible to predict the progression of bone metastasis by identifying biomarkers as risk factors for bone metastasis?
Study Start Date: Sept. 17, 2024
Study Type: INTERVENTIONAL
Condition:
Bone Metastasis
Intervention:
GENETIC: Biomolecular profi...